A Study of SC Administration of Trastuzumab (Herceptin) by SID at Home in HER2-Positive EBC Participants
Clinical trial NCT02040935 · COMPLETED
Trial details
- NCT number
- NCT02040935
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-21
- Primary completion
- 2018-09-14
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.